Form 4 Filing for Evommune, Inc. - Officer Stock Option Grant

This Form 4 filing details a stock option grant to Jeegar Pravinkumar Patel, Chief Scientific Officer of Evommune, Inc. On April 16, 2026, Mr. Patel was granted an employee stock option to acquire 69,315 shares of common stock at an exercise price of $26.77 per share. The option vests over time, with one-fourth vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following 36 months, contingent upon continued service. The transaction is reported as an acquisition of a derivative security.